Category: Health Newsfeed
Parents of children who are not eligible for Covid vaccines are struggling, Elizabeth Tracey reports
With the relaxation of COVID restrictions some common childhood viruses are making an unseasonal comeback, Elizabeth Tracey reports
Podcast: Download (Duration: 1:06 — 1.5MB)
Subscribe: RSS
Respiratory syncytial virus, or RSV, is a viral infection typically experienced early in life, and for most, isn’t a problem. Now more children seem to be experiencing RSV out of season, sometimes along with COVID infection. Helen Hughes, a pediatrician …
Should the intermediaries known as pharmacy benefits managers be reined in to control drug prices? Elizabeth Tracey reports
Podcast: Download (Duration: 1:03 — 1.5MB)
Subscribe: RSS
Medicare could save billions of dollars simply by negotiating drug prices, a recent study found. One group that makes a lot of money acting as an intermediary between payers and patients are pharmacy benefits managers, or PBMs. Caleb Alexander, an …
Should Medicare be allowed to negotiate drug prices? Elizabeth Tracey reports
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
Billions of dollars could be saved by Medicare if they simply negotiated drug prices for the ten most common prescription medicines in the same way Costco does, a recent study found. Caleb Alexander, an internal medicine expert at Johns Hopkins, …
Should Medicare be allowed to negotiate drug prices? Elizabeth Tracey reports Read more »
Should we allow adopt a big retailer approach to common prescription medication provision? Elizabeth Tracey reports
Podcast: Download (Duration: 1:02 — 1.4MB)
Subscribe: RSS
If Medicare adopted the approach taken by Costco in buying and providing common prescription medications the system would save billions of dollars, a recent study showed. Caleb Alexander, an internal medicine expert at Johns Hopkins, says he’s not surprised. Alexander: …
Has the FDA dropped the ball with accelerated approval of drugs? Elizabeth Tracey reports
Podcast: Download (Duration: 1:03 — 1.4MB)
Subscribe: RSS
The Alzheimer’s drug Aduhelm is just the latest misstep in the FDA’s mishandling of accelerated approval, with a recent study showing that almost half of drugs approved this way haven’t done the required confirmatory studies. Caleb Alexander, an internal medicine …